Jane Wasman, Director at SELLAS Life Sciences Group, Inc. (SLS), bought 20,000 shares at $1.69 ($34K) on 2025-05-30, disclosed to the SEC on 2025-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ACOR | SELL | 2018-01-23 | $1.9M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $187K | — | Filing → |
| ACOR | SELL | 2017-02-13 | $2.4M | — | Filing → |